|
|
|
| Analysis of the timeliness of anti-retroviral therapy among newly reported HIV/AIDS cases |
| SU Dehua, CHEN Xiangyang, LI Jun, ZHAO Lina, ZHANG Hemei, ZHU Tingting, HU Wenxue, LAI Jiangyi
|
| Wenzhou Center for Disease Control and Prevention (Wenzhou Institute of Public Health Supervision),Wenzhou, Zhejiang 325000, China |
|
|
|
|
Abstract Objective To analyze the timeliness of antir-etroviral therapy (ART) and its influencing factors among newly reported HIV/AIDS cases in Wenzhou City, Zhejiang Province from 2016 to 2023, so as to provide a reference for improving the ART effect of HIV/AIDS cases. Methods Newly reported HIV/AIDS cases in Wenzhou City from 2016 to 2023 were selected as the research subjects. Demographic information, the situation of the first CD4+ T lymphocyte (CD4 cell) test, baseline CD4 cell count, and ART situation were collected through the Chinese Disease Prevention and Control Information System. The timely rate of ART was analyzed, and the influencing factors for timely ART among HIV/AIDS cases were analyzed using a multivariable logistic regression model. Results A total of 4 500 newly reported HIV/AIDS cases in Wenzhou City from 2016 to 2023 were included, among which 3 679 were males, accounting for 81.76%, and 821 were females, accounting for 18.24%. The median age was 46.24 (interquartile range, 26.23) years. Among these cases, 3 606 received timely ART, with a timely rate of 80.13%. The timely rate of ART increased from 57.54% in 2016 to 91.97% in 2023 (P<0.05). Multivariable logistic regression analysis showed that unmarried/divorced/widowed (OR=0.769, 95%CI: 0.641-0.922), detainees (OR=0.492, 95%CI: 0.269-0.900), untimely first CD4 cell test (OR=0.278, 95%CI: 0.234-0.330), baseline CD4 cell count ≥200 cells/µL (OR=0.709, 95%CI: 0.595-0.843) or undetected (OR=0.131, 95%CI: 0.080-0.213) were associated with a lower timeliness for ART among HIV/AIDS cases. Conclusion From 2016 to 2023, the timely rate of ART among newly reported HIV/AIDS cases in Wenzhou City showed an upward trend, which was mainly affected by marital status, case source, timeliness of the first CD4 cell test, and baseline CD4 cell count.
|
|
Received: 14 March 2025
Revised: 02 July 2025
Published: 20 August 2025
|
|
|
|
|
|
[1] 李瑶,杨景元,杨虹,等.内蒙古自治区艾滋病自愿咨询检测门诊求询者特征分析[J].预防医学,2025,37(4):356-360.
LI Y,YANG J Y,YANG H,et al.Characteristics of individuals attending HIV voluntary counseling and testing clinics in Inner Mongolia Autonomous Region[J].China Prev Med J,2025,37(4):356-360.(in Chinese)
[2] 李倩,杨柏林,陈积标,等.无锡市50岁及以上HIV/AIDS抗病毒治疗病例自报慢性病资料分析[J].预防医学,2025,37(4):390-394.
LI Q,YANG B L,CHEN J B,et al.Self-reported chronic disease prevalence among HIV/AIDS patients aged 50 years and above receiving antiretroviral therapy in Wuxi City[J].China Prev Med J,2025,37(4):390-394.(in Chinese)
[3] ZHA Y,WU Z Y,MCGOOGAN J M,et al.Immediate antiretroviral therapy decreases mortality among patients with high CD4 counts in China:a nationwide,retrospective cohort study[J].Clin Infect Dis,2018,66(5):727-734.
[4] 中国疾病预防控制中心性病艾滋病预防控制中心.国家免费艾滋病抗病毒药物治疗手册[M].5版.北京:人民卫生出版社,2023.
National Center for AIDS/STD Control and Prevention,Chinese Center for Disease Control and Prevention.National free AIDS antiviral treatment manual[M].5th ed.Beijing:People's Medical Publishing House,2023.(in Chinese)
[5] 国务院办公厅.国务院办公厅关于印发中国遏制与防治艾滋病“十三五”行动计划的通知[EB/OL].[2025-07-02].http://www.gov.cn/zhengce/content/2017–02/05/content_5165514.htm.
[6] 孟小聖,李天洲,张绪朋,等.2017—2021年武汉市HIV/AIDS患者抗病毒治疗及时性及影响因素[J].中国艾滋病性病,2023,29(6):714-715.
MENG X S,LI T Z,ZHANG X P,et al.Timeliness of antiviral therapy and influencing factors for HIV/AIDS patients in Wuhan from 2017 to 2021[J].Chin J AIDS STD,2023,29(6):714-715.(in Chinese)
[7] ZHAO Y,WU Z Y,MCGOOGAN J M,et al.Nationwide cohort study of antiretroviral therapy timing:treatment dropout and virological failure in China,2011-2015[J].Clin Infect Dis,2019,68(1):43-50.
[8] 中国疾病预防控制中心性病艾滋病预防控制中心.艾滋病病毒感染者随访工作指南(2016年版)[EB/OL].[2025-07-02].https://jzcdc.cn/gongshigonggao/zhengcefagui/257.html.
[9] 郭燕,赵芳凝,候金余,等.天津市2016—2020年新报告HIV/AIDS患者抗病毒治疗及时性分析[J].中国艾滋病性病,2022,28(1):78-81.
GUO Y,ZHAO F N,HOU J Y,et al.Analyse the timeliness of initiationanti-retroviral treatment among newly diagnosed HIV/AIDS cases in Tianjin[J].Chin J AIDS STD,2022,28(1):78-81.(in Chinese)
[10] 李婧,杨中荣,金玫华,等.湖州市HIV/AIDS患者抗病毒治疗及时性及影响因素分析[J].中国皮肤性病学,2022,36(12):1415-1418.
LI J,YANG Z R,JIN M H,et al.Analysis of factors on timeliness of antiretroviral treatment among HIV/AIDS in Huzhou City[J].Chin J Derm Venerelo,2022,36(12):1415-1418.(in Chinese)
[11] 朱晓艳,黄涛,王国永,等.山东省HIV感染者和艾滋病患者抗病毒治疗及时性及影响因素分析[J].中华实验和临床病毒学杂志,2021,35(4):361-366.
ZHU X Y,HUANG T,WANG G Y,et al.An analysis of factors associated with timeliness of antiretroviral therapy among HIV/AIDS in Shandong province[J].Chinese J Exp Clin Virol,2021,35(4):361-366.(in Chinese)
[12] 张幸,罗明宇,郝晓刚,等.2016—2018年衢州市新报告HIV感染者/AIDS患者抗病毒治疗及时情况与影响因素分析[J].中国预防医学杂志,2020,21(8):929-933.
ZHANG X,LUO M Y,HAO X G,et al.Timely initiation of antiretroviral treatment for newly diagnosed HIV/AIDS and its influencing factors in Quzhou in 2016-2018[J].Chin Prev Med,2020,21(8):929-933.(in Chinese)
[13] 陈洁,覃碧云,魏秀青,等.2016—2020年湖南省新报告成年HIV/AIDS病例抗病毒治疗及时性及影响因素分析[J].实用预防医学,2022,29(12):1409-1413.
CHEN J,QIN B Y,WEI X Q,et al.Timeliness of antiretroviral therapy in intiation and its influencing factors among newly reported HIV/AIDS adult cases in Hunan Province,2016-2020[J].Pract Prev Med,2022,29(12):1409-1413.(in Chinese)
[14] 李莉,杜明庆,王子夫,等.2016—2022年临沂市HIV/AIDS患者抗病毒治疗及时性及影响因素分析[J].中国初级卫生保健,2024,38(5):58-61.
LI L,DU M Q,WANG Z F,et al.Analysis on the timeliness of antiretroviral treatment and influencing factors among newly reported HIV/AIDS cases in Linyi from 2016 to 2022[J].Chin Prim Health Care,2024,38(5):58-61.(in Chinese)
[15] VOJNOV L,MARKBY J,BOEKE C,et al.POC CD4 testing improves linkage to HIV care and timeliness of ART initiation in a public health approach:a systematic review and mete-analysis[J/OL].PLoS One,2016,11(5)[2025-07-02].https://doi.org/10.1371/journal.pone.0155256.
[16] 闵洁,赵丁源,张皓,等.2016—2022 年宜昌市新报告HIV/AIDS病例抗病毒治疗及时性分析[J].公共卫生与预防医学,2024,35(5):117-120
MIN J,ZHAO D Y,ZHANG H,et al.Timeliness of antiviral therapy for newly reported HIV/AIDS cases in Yichang City in 2016-2022[J].J Public Health Prev Med,2024,35(5):117-120.(in Chinese)
[17] 蔡衍珊,罗业飞,樊莉蕊,等.广州市2019年新报告HIV/AIDS病例确诊后30 d内接受抗病毒治疗分析[J].现代预防医学,2020,47(23):4366-4369. |
|
|
|
